NCT05109728 2026-03-16A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.NovartisPhase 1 Active not recruiting65 enrolled